Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Versartis Inc (VSAR)

Versartis Inc (VSAR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,126
  • Shares Outstanding, K 36,240
  • Annual Sales, $ 40,000 K
  • Annual Income, $ -84,980 K
  • 60-Month Beta 1.94
  • Price/Sales 1,096.29
  • Price/Cash Flow N/A
  • Price/Book 0.62
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.35
  • Most Recent Earnings -1.40 on 10/26/17
  • Next Earnings Date 10/25/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.40
  • Growth Rate Est. (year over year) +71,457.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.14 +4.39%
on 10/12/18
1.60 -25.62%
on 09/27/18
-0.26 (-17.93%)
since 09/14/18
3-Month
1.14 +4.39%
on 10/12/18
2.10 -43.33%
on 07/24/18
-0.86 (-41.95%)
since 07/13/18
52-Week
1.14 +4.39%
on 10/12/18
2.76 -56.81%
on 10/19/17
-1.41 (-54.23%)
since 10/13/17
Trade VSAR with:

Business Summary

Versartis, Inc. operates as a biotechnology company. It develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders. The Company is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase 2a clinical trials for the treatment of growth hormone...

See More

Key Turning Points

2nd Resistance Point 1.34
1st Resistance Point 1.27
Last Price 1.19
1st Support Level 1.15
2nd Support Level 1.10

See More

52-Week High 2.76
Fibonacci 61.8% 2.14
Fibonacci 50% 1.95
Fibonacci 38.2% 1.76
Last Price 1.19
52-Week Low 1.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar